Dankook University Hospital Professor Hyun Jungkeun's Team Confirms Anti-Cancer Drug's Effect in Suppressing Sarcopenia

Published in JCSM and Featured in Hanbitsa

Professor Hyun Junggeun and paper.

Dankook University Hospital in Cheonan, Chungnam, announced on the 14th that Professor Hyun Jeonggeun's research team has confirmed the effect of the anticancer drug Lenvatinib in suppressing sarcopenia.

Sarcopenia, which mainly occurs due to aging, is closely associated with increased risk of falls, loss of function, and higher mortality rates.

Professor Hyun's team confirmed through animal models that Lenvatinib activates mitochondrial function in muscle cells and inhibits muscle loss.

In particular, since the safety of the existing drug has already been proven, there is a high possibility that it could be clinically repurposed as a treatment for sarcopenia.

This achievement was recently published in the world-renowned journal 'Journal of Cachexia, Sarcopenia and Muscle (JCSM)' and featured in the major Korean scientific community 'Hanbitsa.'

Professor Hyun stated, "I hope this research can provide practical help to patients in the field of regenerative medicine," and added, "We will continue to develop patient-centered treatments and pursue research utilizing advanced technologies."

This content was produced with the assistance of AI translation services.